Stem cells and repair of the heart

Lancet

Volumn 364, Issue 9429, 2004, Pages 183-192

  Mathur, A ^a,b   Martin, J F ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DERIVATIVE;

AMPHIBIA; ARTERY DISEASE; ATHEROSCLEROSIS; BRAIN INFARCTION; CAUSE OF DEATH; CELL FUSION; CELL HYBRIDIZATION; CELL REGENERATION; CONFERENCE PAPER; CORRELATION ANALYSIS; HEART FAILURE; HEART INFARCTION; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART SURGERY; HUMAN; MEDICAL RESEARCH; MITOSIS; MOLECULAR MECHANICS; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; Y CHROMOSOME;

EID: 3142554538     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16632-4     Document Type: Conference Paper

References (123)

1. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 107:2001;1395-1402
2. Eisenberg LM, Eisenberg CA. Adult stem cells and their cardiac potential. Anat Rec. 276:2004;103-112
3. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 83:1998;15-26
4. MacLellan WR, Schneider MD. Genetic dissection of cardiac growth control pathways. Annu Rev Physiol. 62:2000;289-319
5. Chien KR, Olson EN. Converging pathways and principles in heart development and disease: CV@CSH. Cell. 110:2002;153-162
6. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 95:1998;8801-8805
7. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 344:2001;1750-1757
8. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med. 346:2002;5-15
9. Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res. 90:2002;634-640
10. Muller P, Pfeiffer P, Koglin J, et al. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts. Circulation. 106:2002;31-35
11. Deb A, Wang S, Skelding KA, Miller D, Simper D, Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart: a study of gender-mismatched bone marrow transplantation patients. Circulation. 107:2003;1247-1249
12. Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA. 98:2001;10344-10349
13. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 107:2001;1395-1402
14. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA, Megeney LA. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 530:2002;239-243
15. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA. 100:2003;12313-12318
16. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 114:2003;763-776
17. Hughes S. Cardiac stem cells. J Pathol. 197:2002;468-478
18. Wessels A, Perez-Pomares JM. The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec. 276:2004;43-57
19. Douglas BS. Conservative management of guillotine amputation of the finger in children. Aust Paediatr J. 8:1972;86-89
20. Holm A, Zachariae L. Fingertip lesions. An evaluation of conservative treatment versus free skin grafting. Acta Orthop Scand. 45:1974;382-392
21. King PA. Trapped finger injury. Med J Aust. 2:1979;580-582
22. Soderberg T, Nystrom A, Hallmans G, Hulten J. Treatment of fingertip amputations with bone exposure. A comparative study between surgical and conservative treatment methods. Scand J Plast Reconstr Surg. 17:1983;147-152
23. O'Hara CM, Egar MW, Chernoff EA. Reorganization of the ependyma during axolotl spinal cord regeneration: changes in intermediate filament and fibronectin expression. Dev Dyn. 193:1992;103-115
24. O'Steen WK, Walker BE. Radioautographic studies or regeneration in the common newt. III. Regeneration and repair of the intestine. Anat Rec. 142:1962;179-187
25. Oberpriller JO, Oberpriller JC. Cell Division in adult newt cardiac myocytes. Oberpriller JO, Oberpriller JC, Mauro A. The developmental and regeneration potential of cardiac muscle. 1991;293-311 Harwood, New York
26. Nye HL, Cameron JA, Chernoff EA, Stocum DL. Regeneration of the urodele limb: a review. Dev Dyn. 226:2003;280-294
27. Tsonis PA. Regeneration of the lens in amphibia. Fini E. Vertebrate eye development. 2000;Spinger-Verlag, Heidelberg
28. Mullen LM, Bryant SV, Torok MA, Blumberg B, Gardiner DM. Nerve dependency of regeneration: the role of Distal-less and FGF signaling in amphibian limb regeneration. Development. 122:1996;3487-3497
29. D'Jamoos CA, McMahon G, Tsonis PA. Fibroblast growth factor receptors regulate the ability for hindlimb regeneration in Xenopus laevis. Wound Repair Regen. 6:1998;388-397
30. Cardoso MC, Leonhardt H, Nadal-Ginard B. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell. 74:1993;979-992
31. Tsonis PA, Del Rio-Tsonis K. Spontaneous neoplasms in amphibia. Tumour Biol. 9:1988;221-224
32. Eguchi G, Watanabe K. Elicitation of lens formation from the "ventral iris" epithelium of the newt by a carcinogen, N-methyl-N′-nitro-N-nitrosoguanidine. J Embryol Exp Morphol. 30:1973;63-71
33. Tsonis PA. Effects of carcinogens on regenerating and non-regenerating limbs in amphibia (review). Anticancer Res. 3:1983;195-202
34. Prehn RT. Immunosurveillance, regeneration and oncogenesis. Prog Exp Tumor Res. 14:1971;1-24
35. Verfaillie CM. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol. 12:2002;502-508
36. Orkin SH, Zon LI. Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat Immunol. 3:2002;323-328
37. Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nat Med. 7:2001;393-395
38. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 416:2002;542-545
39. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature. 416:2002;545-548
40. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature. 422:2003;901-904
41. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 422:2003;897-901
42. Hawley RG, Sobieski DA. Somatic stem cell plasticity: to be or not to be. Stem Cells. 20:2002;195-197
43. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 297:2002;2256-2259
44. Wells WA. Is transdifferentiation in trouble? J Cell Biol. 157:2002;15-18
45. Wurmser AE, Gage FH. Stem cells: cell fusion causes confusion. Nature. 416:2002;485-487
46. Medvinsky A, Smith A. Stem cells: fusion brings down barriers. Nature. 422:2003;823-885
47. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 100:1999;247-256
48. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 105:2002;93-98
49. Wang JS, Shum-Tim D, Galipeau J, Chedrawy E, Eliopoulos N, Chiu RC. Marrow stromal cells for cellular cardiomyoplasty: feasibility and potential clinical advantages. J Thorac Cardiovasc Surg. 120:2000;999-1005
50. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 410:2001;701-705
51. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci USA. 938:2001;221-230
52. Satomi-Kobayashi S, Kawashima S, Sakoda T, et al. Cardiac myocytes are recruited by bone marrow-derived cells in intact murine heart. Kobe J Med Sci. 48:2002;161-166
53. Saito T, Kuang JQ, Lin CC, Chiu RC. Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction. J Thorac Cardiovasc Surg. 126:2003;114-123
54. Kuramochi Y, Fukazawa R, Migita M, et al. Cardiomyocyte regeneration from circulating bone marrow cells in mice. Pediatr Res. 54:2003;319-325
55. Ciulla MM, Lazzari L, Pacchiana R, et al. Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury. Haematologica. 88:2003;614-621
56. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature. 425:2003;968-973
57. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 428:2004;664-668
58. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 428:2004;668-673
59. Chien KR. Stem cells: lost in translation. Nature. 428:2004;607-608
60. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 85:1999;221-228
61. Fuchs S, Baffour R, Zhou YF, et al. Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia. J Am Coll Cardiol. 37:2001;1726-1732
62. Hamano K, Li TS, Kobayashi T, et al. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann Thorac Surg. 73:2002;1210-1215
63. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 104:2001;1046-1052
64. Kamihata H, Matsubara H, Nishiue T, et al. Improvement of collateral perfusion and regional function by implantation of peripheral blood mononuclear cells into ischemic hibernating myocardium. Arterioscler Thromb Vasc Biol. 22:2002;1804-1810
65. Kobayashi T, Hamano K, Li TS, et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res. 89:2000;189-195
66. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 7:2001;430-436
67. Nishida M, Li TS, Hirata K, Yano M, Matsuzaki M, Hamano K. Improvement of cardiac function by bone marrow cell implantation in a rat hypoperfusion heart model. Ann Thorac Surg. 75:(3):2003;768-774
68. Norol F, Merlet P, Isnard R, et al. Influence of mobilized stem cells on myocardial infarct repair in a nonhuman primate model. Blood. 102:2003;436-468
69. Van Meter CH Jr, Claycomb WC, Delcarpio JB, et al. Myoblast transplantation in the porcine model: a potential technique for myocardial repair. J Thorac Cardiovasc Surg. 110:1995;1442-1448
70. Li RK, Mickle DA, Weisel RD, et al. Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. Circulation 1997; 96 (suppl): 179-87.
71. Watanabe E, Smith DM Jr, Delcarpio JB, et al. Cardiomyocyte transplantation in a porcine myocardial infarction model. Cell Transplant. 7:1998;239-246
72. Li RK, Jia ZQ, Weisel RD, Mickle DA, Choi A, Yau TM. Survival and function of bioengineered cardiac grafts. Circulation 1999; 100 (suppl): 63-69.
73. Leor J, Aboulafia-Etzion S, Dar A, et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation. 102:(suppl 3):2000;56-61
74. Sakakibara Y, Nishimura K, Tambara K, et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg. 124:2002;50-56
75. Miyagawa S, Sawa Y, Taketani S, et al. Myocardial regeneration therapy for heart failure: hepatocyte growth factor enhances the effect of cellular cardiomyoplasty. Circulation. 105:2002;2556-2561
76. Shimizu T, Yamato M, Isoi Y, et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res. 90:2002;40
77. Eschenhagen T, Didie M, Heubach J, Ravens U, Zimmermann WH. Cardiac tissue engineering. Transpl Immunol. 9:2002;315-321
78. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li RK. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 104:(suppl 1):2001;218-222
79. Koh GY, Kim SJ, Klug MG, Park K, Soonpaa MH, Field LJ. Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest. 95:1995;114-121
80. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation. 102:2000;898-901
81. Suzuki K, Murtuza B, Smolenski RT, et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation. 104:(suppl 1):2001;207-212
82. Behfar A, Zingman LV, Hodgson DM, et al. Stem cell differentiation requires a paracrine pathway in the heart. Faseb J. 16:2002;1558-1566
83. Yang Y, Min JY, Rana JS, et al. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells. J Appl Physiol. 93:2002;1140-1151
84. Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 123:2002;1132-1140
85. Hruban RH, Long PP, Perlman EJ, et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol. 142:1993;975-980
86. Glaser R, Lu MM, Narula N, Epstein JA. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation. 106:2002;17-19
87. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med. 346:2002;5-15
88. Dowell JD, Rubart M, Pasumarthi KB, Soonpaa MH, Field LJ. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res. 58:2003;336-350
89. Lanza R, Moore MA, Wakayama T, et al. Regeneration of the infarcted heart with stem cells derived by nuclear transplantation. Circ Res. 94:2004;820-827
90. Auchincloss H, Bonventre JV. Transplanting cloned cells into therapeutic promise. Nat Biotechnol. 20:2002;665-666
91. Lanza RP, Cibelli JB, West MD. Prospects for the use of nuclear transfer in human transplantation. Nat Biotechnol. 17:1999;1171-1174
92. Lanza RP, Cibelli JB, West MD. Human therapeutic cloning. Nat Med. 5:1999;975-977
93. Lanza RP, Caplan AL, Silver LM, Cibelli JB, West MD, Green RM. The ethical validity of using nuclear transfer in human transplantation. Jama. 284:2000;3175-3179
94. Assmus B, Schachinger V, Teupe C, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 106:2002;3009-3017
95. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 106:2002;1913-1918
96. Wollert KM, Lotz GP, Ringes-Lichtenberg J, et al. Intracoroanry autologous bone-marrow cell transfer after myocardial infarction: randomised controlled clinical trial. Lancet. 364:2004;141-148
97. Aviles FF, San Roman JA, Garcia Frade J, et al. Intracoronary stem cell transplantation in acute myocardial infarction. Rev Esp Cardiol. 57:2004;201-208
98. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet. 363:2004;751-756
99. Perin EC, Dohmann HF, Borojevic R, et al. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 107:2003;2294-2302
100. Ozbaran M, Omay SB, Nalbantgil S, et al. Autologous peripheral stem cell transplantation in patients with congestive heart failure due to ischemic heart disease. Eur J Cardiothorac Surg. 25:2004;342-511
101. Li TS, Hamano K, Hirata K, Kobayashi T, Nishida M. The safety and feasibility of the local implantation of autologous bone marrow cells for ischemic heart disease. J Card Surg. 18:(suppl 2):2003;69-75
102. Galinanes M, Loubani M, Davies J, Chin D, Pasi J, Bell PR. Autotransplantation of unmanipulated bone marrow into scarred myocardium is safe and enhances cardiac function in humans. Cell Transplant. 13:2004;7-13
103. Siminiak T, Grygielska B, Jerzykowska O, et al. Autologous bone marrow stem cell transplantation in acute myocardial infarction-report on two cases. Kardiol Pol. 59:2003;502-510
104. Stamm C, Westphal B, Kleine HD, et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 361:2003;45-46
105. Hill JP, Paul JD, Powell TM. Efficacy and risk of granulocyte colony stimulating factor administration in patients with severe coronary artery disease. Circulation. 108:(suppl 4):2003;478
106. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet. 363:2004;783-784
107. Sakai T, Li R-K, Weisel RD, et al. Fetal cell transplantation: a comparison of three cell types. J Thor Cardiovasc Surg. 118:1999;715-725
108. Chiu RC-J, Zibaitis A, Kao RL. Cellular cardiomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg. 60:1995;12-18
109. Murry CE, Wiseman RW, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 98:1996;2512-2523
110. Taylor DA, Atkins BZ, Hungspreugs P, et al. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 4:1998;929-933
111. Scorsin M, Hagege A, Vilquin J-T, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. J Thorac Cardiovasc Surg. 119:2000;1169-1175
112. Menasche P, Hagege AA, Scorsin M, et al. Myoblast transplantation for heart failure. Lancet. 357:2001;279-280
113. Menasche P, Hagege AA, Vilquin JT, et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol. 41:2003;1078-1083
114. Herreros J, Prosper F, Perez A, et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J. 24:2003;2012-2020
115. Smits PC, van Geuns RJ, Poldermans D, et al. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol. 42:2003;2063-2069
116. Siminiak T, Fiszer D, Jerzykowska O, Grygielska B, Kalmucki P, Kurpisz M. Percutaneous autologous myoblast transplantation in the treatment of post-infarction myocardial contractility impairment-report on two cases. Kardiol Pol. 59:2003;492-501
117. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet. 355:2000;213-222
118. Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann.Thorac. Surg. 73:2002;1919-1925
119. Orlic D. Stem cell repair in ischemic heart disease: an experimental model. Int J Hematol. 76:(suppl 1):2002;144-145
120. Yau TM, Tomita S, Weisel RD, et al. Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells. Ann Thorac Surg. 75:2003;169-177
121. Iten LB, SV. Forelimb regeneration from different levels of amputation in the newt N. viridescens. Length, rate and stages. Wilhelm Roux Arch Dev Biol. 1973; 173: 263-282.
122. Bittner RE, Schofer C, Weipoltshammer K, et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl). 199:1999;391-396
123. Isner JM. Myocardial gene therapy. Nature. 415:2002;234-239